Glycoprotein IIb/IIIa Inhibitors to Facilitate Percutaneous Intervention in ST-Elevation Myocardial Infarction - The Sooner not Necessarily the Better

被引：1
|
作者：
Guzman, Luis A. [1 ,2 ]
机构：
[1] Univ Florida, Ctr Cardiovasc, Coll Med, Jacksonville, FL 32209 USA
[2] Univ Florida, Coll Med, Cardiac Catheterizat Lab, Jacksonville, FL 32209 USA
来源：
CIRCULATION JOURNAL | 2010年 / 74卷 / 08期
关键词：
CORONARY INTERVENTION; RANDOMIZED-TRIAL; ASSENT-4; PCI; REPERFUSION; ANGIOPLASTY; SURVIVAL;
D O I：
10.1253/circj.CJ-10-0509
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1528 / 1529
页数：2
相关论文
共 50 条
  • [1] The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction
    Svilaas, T
    van der Horst, ICC
    Zijlstra, F
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (23) : 2479 - 2481
  • [2] Clinical Benefits of Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Elevation Myocardial Infarction
    Sim, Doo Sun
    Ahn, Youngkeun
    Jeong, Myung Ho
    Kim, Young Jo
    Chae, Shung Chull
    Hong, Taek Jong
    Seong, In Whan
    Chae, Jei Keon
    Kim, Chong Jin
    Cho, Myeong Chan
    Seung, Ki Bae
    Park, Seung Jung
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 36B - 36B
  • [3] Is Still There a Place for Glycoprotein IIb-IIIa Inhibitors in Modern Treatment of ST-Elevation Myocardial Infarction?
    Jorge, Elisabete
    Baptista, Rui
    Teixeira, Rogerio
    Saraiva, Fatima
    Mendes, Paulo
    Lourenco, Carolina
    Goncalves, Francisco
    Monteiro, Pedro
    Freitas, Mario
    Providencia, La
    [J]. CIRCULATION, 2010, 122 (02) : E249 - E249
  • [4] Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction
    Holper, EM
    Giugliano, RP
    Antman, EM
    [J]. CORONARY ARTERY DISEASE, 1999, 10 (08) : 567 - 573
  • [5] Clinical Benefits of Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Elevation Myocardial Infarction Pretreated with Clopidogrel before Primary Percutaneous Coronary Intervention
    Sim, Don Sun
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 33B - 33B
  • [6] Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
    Tereshchenko, Andrey S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (06) : 918 - 927
  • [7] Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction
    Howard, J. P.
    Jones, D. A.
    Gallagher, S.
    Rathod, K.
    Antoniou, S.
    Wright, P.
    Knight, C.
    Mathur, A.
    Weerackody, R.
    Wragg, A.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [8] Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: Will the combination with thrombolytics become reality?
    Zeymer, U
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2003, 15 (02) : 91 - 97
  • [9] Glycoprotein IIb/IIIa Receptor Inhibitors in Acute ST-Elevation Myocardial Infarction: Will the Combination with Thrombolytics Become Reality?
    Uwe Zeymer
    [J]. Journal of Thrombosis and Thrombolysis, 2003, 15 : 91 - 97
  • [10] The use of glycoprotein IIb/IIIa receptor blockers in primary percutaneous coronary intervention for ST-elevation myocardial infarction: results of the international Shakespeare Registry
    Gitt, AK
    Gottwik, MG
    Bassand, JP
    Seabra-Gomes, R
    Hasdai, D
    Fioretti, P
    Dawkins, K
    Senges, J
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 269 - 269
12345